Publication | Closed Access

Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats

Angiotensin Ii ActionMetabolic SyndromeInsulin SignalingMolecular PhysiologySignal TransductionAngiogenesisMedicineVascular PharmacologyPhysiologyDiabetesEndothelial DysfunctionVascular BiologyHypertensive RatsPharmacologyCell BiologyCell SignalingHealth Sciences